A Comprehensive Overview on Pharmacological and Therapeutic Insights of Solanum nigrum Linn

preprint OA: closed
Full text JSON View at publisher

Abstract

_Solanum nigrum _is a traditional Chinese bush renowned for its dynamic therapeutic activities in the Indian and Chinese systems of medicine. It is a typical, palatable herbal remedy that belongs to the family Solanaceae. This overview assembles the prospective pharmacological and medicinal significance of the last three decades' accomplishments of scholarly reports from internet sources and publications. According to several literature reviews, _Solanum nigrum_ encompasses a variety of phytochemical compounds that could be isolated and identified using various extraction techniques. The major chemical components of this herb are alkaloids, glycoproteins, polysaccharides, and phenolic compounds with a broad spectrum of pharmacological outcomes such as anticancer, immunostimulant, antibacterial, antidiabetic, antiviral, antiinflammatory, antioxidant, antipyretic, antidiarrheal, cardioprotective, anti-hyperlipidemic, anti-ulcerogenic, hepatoprotective, anti-seizure, anti-larvicidal, anti-allergic, anti-asthmatic, and neuropharmacological efficacy. Recently, scientists and researchers have been searching for potentially biologically active plants due to the increasing toxicity and adverse effects of modern synthetic drugs. As every part of _Solanum nigrum _contains a variety of therapeutically active phytochemicals, it could be a significant source for scientists to conduct further research and discover the proper mechanism for preventing diseases. In conclusion, _Solanum nigrum_ emerges as a valuable resource in the pursuit of alternative therapeutic options. Its multifaceted pharmacological properties and traditional usage underscore its potential significance in modern healthcare.
Full text 621 characters · extracted from oa-doi-fallback · click to expand
There is a newer version available for this {{ publicationType }}. View latest version {{ publication.field_name }} {{ publication.subfield_name }} Copyright: © {{ publicationYear }} {{ publication.presentation_authors[0].full_name + (publication.presentation_authors.length > 1 ? ' et al' : '') }}. This is an open access publication distributed under the terms of the CC BY 4.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Check the {{ publicationType | capitalize }} Source for copyright and license information. Listen on

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00